{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T10:06:45Z","timestamp":1780394805966,"version":"3.54.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":43,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04355-x","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T15:12:49Z","timestamp":1776697969000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["RGS19 drives tumor progression and immunosuppression in clear cell renal cell carcinoma by modulating CAMs and EMT"],"prefix":"10.1186","volume":"24","author":[{"given":"Zhenhui","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhusheng","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"issue":"12","key":"4355_CR1","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1001\/jama.2024.12848","volume":"332","author":"TL Rose","year":"2024","unstructured":"Rose TL, Kim WY. Renal cell carcinoma: a review. JAMA. 2024;332(12):1001\u201310. https:\/\/doi.org\/10.1001\/jama.2024.12848.","journal-title":"JAMA"},{"issue":"5","key":"4355_CR2","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.eururo.2022.08.019","volume":"82","author":"L Bukavina","year":"2022","unstructured":"Bukavina L, Bensalah K, Bray F, et al. Epidemiology of renal cell carcinoma: 2022 update. Eur Urol. 2022;82(5):529\u201342. https:\/\/doi.org\/10.1016\/j.eururo.2022.08.019.","journal-title":"Eur Urol"},{"issue":"4","key":"4355_CR3","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41571-020-00455-z","volume":"18","author":"DA Braun","year":"2021","unstructured":"Braun DA, Bakouny Z, Hirsch L, et al. Beyond conventional immune-checkpoint inhibition - novel immunotherapies for renal cell carcinoma. Nat Rev Clin Oncol. 2021;18(4):199\u2013214. https:\/\/doi.org\/10.1038\/s41571-020-00455-z. Epub 2021 Jan 12.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"4355_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.eururo.2024.10.019","volume":"87","author":"R Barragan-Carrillo","year":"2025","unstructured":"Barragan-Carrillo R, Saad E, Saliby RM, et al. First and Second-line treatments in metastatic renal cell carcinoma. Eur Urol. 2025;87(2):143\u201354. https:\/\/doi.org\/10.1016\/j.eururo.2024.10.019.","journal-title":"Eur Urol"},{"key":"4355_CR5","doi-asserted-by":"publisher","unstructured":"Masuho I, Balaji S, Muntean BS et al. A global map of g protein signaling regulation by RGS proteins. Cell. 2020;183(2):503\u2013521.e19. https:\/\/doi.org\/10.1016\/j.cell.2020.08.052. Epub 2020 Oct 1.","DOI":"10.1016\/j.cell.2020.08.052"},{"issue":"3","key":"4355_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/s0092-8674(00)80117-8","volume":"86","author":"DM Berman","year":"1996","unstructured":"Berman DM, Wilkie TM, Gilman AG. GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell. 1996;86(3):445\u201352. https:\/\/doi.org\/10.1016\/s0092-8674(00)80117-8.","journal-title":"Cell"},{"issue":"3","key":"4355_CR7","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1091\/mbc.12.3.615","volume":"12","author":"X Lou","year":"2001","unstructured":"Lou X, Yano H, Lee F, et al. GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways. Mol Biol Cell. 2001;12(3):615\u201327. https:\/\/doi.org\/10.1091\/mbc.12.3.615.","journal-title":"Mol Biol Cell"},{"issue":"2","key":"4355_CR8","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.canlet.2011.06.002","volume":"309","author":"PH Tso","year":"2011","unstructured":"Tso PH, Yung LY, Wang Y, et al. RGS19 stimulates cell proliferation by deregulating cell cycle control and enhancing Akt signaling. Cancer Lett. 2011;309(2):199\u2013208. https:\/\/doi.org\/10.1016\/j.canlet.2011.06.002.","journal-title":"Cancer Lett"},{"issue":"4","key":"4355_CR9","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1161\/01.RES.0000158287.49872.4e","volume":"96","author":"EL Riddle","year":"2005","unstructured":"Riddle EL, Schwartzman RA, Bond M, et al. Multi-tasking RGS proteins in the heart: the next therapeutic target? Circ Res. 2005;96(4):401\u201311. https:\/\/doi.org\/10.1161\/01.RES.0000158287.49872.4e.","journal-title":"Circ Res"},{"issue":"71","key":"4355_CR10","doi-asserted-by":"publisher","first-page":"eabh1873","DOI":"10.1126\/sciimmunol.abh1873","volume":"7","author":"N Weisshaar","year":"2022","unstructured":"Weisshaar N, Wu J, Ming Y, Madi A, et al. Rgs16 promotes antitumor CD8\u2009+\u2009T cell exhaustion. Sci Immunol. 2022;7(71):eabh1873. https:\/\/doi.org\/10.1126\/sciimmunol.abh1873.","journal-title":"Sci Immunol"},{"issue":"7","key":"4355_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/s41590-021-00939-9","volume":"22","author":"D Huang","year":"2021","unstructured":"Huang D, Chen X, Zeng X, et al. Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer. Nat Immunol. 2021;22(7):865\u201379. https:\/\/doi.org\/10.1038\/s41590-021-00939-9. Epub 2021 Jun 17.","journal-title":"Nat Immunol"},{"issue":"1","key":"4355_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41420-025-02734-z","volume":"11","author":"S Abraham Gnanadass","year":"2025","unstructured":"Abraham Gnanadass S, Pandey S, Viswanathan P. Decoding cuproptosis and cuproplasia: implications for therapeutic strategies in renal cell carcinoma. Cell Death Discov. 2025;11(1):501. https:\/\/doi.org\/10.1038\/s41420-025-02734-z.","journal-title":"Cell Death Discov"},{"issue":"6564","key":"4355_CR13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1126\/science.abf1730","volume":"374","author":"C Li","year":"2021","unstructured":"Li C, Vides A, Kim D, et al. The G protein signaling regulator RGS3 enhances the GTPase activity of KRAS. Science. 2021;374(6564):197\u2013201. https:\/\/doi.org\/10.1126\/science.abf1730. Epub 2021 Oct 7.","journal-title":"Science"},{"issue":"6","key":"4355_CR14","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1038\/emm.2013.49","volume":"45","author":"M Katoh","year":"2013","unstructured":"Katoh M. Functional proteomics, human genetics and cancer biology of GIPC family members. Exp Mol Med. 2013;45(6):e26. https:\/\/doi.org\/10.1038\/emm.2013.49.","journal-title":"Exp Mol Med"},{"issue":"7946","key":"4355_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/s41586-022-05622-z","volume":"614","author":"AJ Stevens","year":"2023","unstructured":"Stevens AJ, Harris AR, Gerdts J, et al. Programming multicellular assembly with synthetic cell adhesion molecules. Nature. 2023;614(7946):144\u201352. https:\/\/doi.org\/10.1038\/s41586-022-05622-z. Epub 2022 Dec 12.","journal-title":"Nature"},{"key":"4355_CR16","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.semcancer.2022.12.002","volume":"88","author":"J Zhang","year":"2023","unstructured":"Zhang J, Hu Z, Horta CA, et al. Regulation of epithelial-mesenchymal transition by tumor microenvironmental signals and its implication in cancer therapeutics. Semin Cancer Biol. 2023;88:46\u201366. Epub 2022 Dec 13.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"4355_CR17","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13045-025-01717-y","volume":"18","author":"Q Hu","year":"2025","unstructured":"Hu Q, Zhu Y, Mei J, et al. Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy. J Hematol Oncol. 2025;18(1):65. https:\/\/doi.org\/10.1186\/s13045-025-01717-y.","journal-title":"J Hematol Oncol"},{"key":"4355_CR18","doi-asserted-by":"publisher","first-page":"105070","DOI":"10.1016\/j.ebiom.2024.105070","volume":"103","author":"S Zhang","year":"2024","unstructured":"Zhang S, Fang T, He Y, et al. VHL mutation drives human clear cell renal cell carcinoma progression through PI3K\/AKT-dependent cholesteryl ester accumulation. EBioMedicine. 2024;103:105070. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105070. Epub 2024 Apr 1.","journal-title":"EBioMedicine"},{"issue":"1","key":"4355_CR19","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12964-025-02131-0","volume":"23","author":"R Huilcaman","year":"2025","unstructured":"Huilcaman R, Campos A, Contreras P, et al. Inclusion of \u0391V\u03b23 integrin into extracellular vesicles in a caveolin-1 tyrosine-14- phosphorylation dependent manner and subsequent transfer to recipient melanoma cells promotes migration, invasion and metastasis. Cell Commun Signal. 2025;23(1):139. https:\/\/doi.org\/10.1186\/s12964-025-02131-0.","journal-title":"Cell Commun Signal"},{"issue":"D1","key":"4355_CR20","doi-asserted-by":"publisher","first-page":"D138","DOI":"10.1093\/nar\/gkad965","volume":"52","author":"E Clough","year":"2024","unstructured":"Clough E, Barrett T, Wilhite SE, et al. NCBI GEO: archive for gene expression and epigenomics data sets: 23-year update. Nucleic Acids Res. 2024;52(D1):D138\u201344. https:\/\/doi.org\/10.1093\/nar\/gkad965.","journal-title":"Nucleic Acids Res"},{"key":"4355_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2018.02.052","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Cancer Genome Atlas Research Network, Hu H, et al. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173(2):400\u2013e41611. https:\/\/doi.org\/10.1016\/j.cell.2018.02.052.\u00a0"},{"issue":"10451","key":"4355_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/S0140-6736(24)00917-6","volume":"404","author":"M Young","year":"2024","unstructured":"Young M, Jackson-Spence F, Beltran L, et al. Renal cell carcinoma. Lancet. 2024;404(10451):476\u201391. https:\/\/doi.org\/10.1016\/S0140-6736(24)00917-6.","journal-title":"Lancet"},{"key":"4355_CR23","doi-asserted-by":"publisher","unstructured":"Cho J, Min HY, Lee HJ et al. RGS2-mediated translational control mediates cancer cell dormancy and tumor relapse. Erratum in: J Clin Invest. 2023;133(10):e171901. https:\/\/doi.org\/10.1172\/JCI171901 J Clin Invest. 2021;131(1):e136779. 10.1172\/JCI136779.","DOI":"10.1172\/JCI171901"},{"issue":"11","key":"4355_CR24","doi-asserted-by":"publisher","first-page":"3052","DOI":"10.1038\/s41418-021-00801-3","volume":"28","author":"S Dasgupta","year":"2021","unstructured":"Dasgupta S, Ghosh T, Dhar J, et al. RGS5-TGF\u03b2-Smad2\/3 axis switches pro- to anti-apoptotic signaling in tumor-residing pericytes, assisting tumor growth. Cell Death Differ. 2021;28(11):3052\u201376. https:\/\/doi.org\/10.1038\/s41418-021-00801-3.","journal-title":"Cell Death Differ"},{"issue":"2","key":"4355_CR25","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384. https:\/\/doi.org\/10.1038\/s41580-018-0080-4.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"4355_CR26","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nrm3758","volume":"15","author":"S Lamouille","year":"2014","unstructured":"Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15(3):178\u201396. https:\/\/doi.org\/10.1038\/nrm3758.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4355_CR27","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/s41420-025-02503-y","volume":"11","author":"DM Xu","year":"2025","unstructured":"Xu DM, Chen LX, Xue T, Zhuang XY, Wei LC, Han H, Mo M. Decoding the impact of MMP1\u2009+\u2009malignant subsets on tumor-immune interactions: insights from single-cell and spatial transcriptomics. Cell Death Discov. 2025;11(1):244. https:\/\/doi.org\/10.1038\/s41420-025-02503-y.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4355_CR28","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1186\/s12967-025-06596-y","volume":"23","author":"Q Wang","year":"2025","unstructured":"Wang Q, Feng W, Tan Y, Qiao J, Liu H, Liu Q, Wang H, Zhang Q, Tao J, Li Z, Yang B, Xu Z, Wang C, Yang S, Cui L. Antiphospholipid antibodies inhibit the migration and invasion of trophoblast cells by suppressing the JNK\/C-Jun\/MMP1 signaling pathway. J Transl Med. 2025;23(1):581. https:\/\/doi.org\/10.1186\/s12967-025-06596-y.","journal-title":"J Transl Med"},{"issue":"5","key":"4355_CR29","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.gendis.2025.101529","volume":"12","author":"S Tian","year":"2025","unstructured":"Tian S, Chen X, Li J. Zinc finger transcription factor ZNF24 inhibits colorectal cancer growth and metastasis by suppressing MMP2 transcription. Genes Dis. 2025;12(5):101529. https:\/\/doi.org\/10.1016\/j.gendis.2025.101529.","journal-title":"Genes Dis"},{"issue":"1","key":"4355_CR30","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/s41420-024-01962-z","volume":"10","author":"P Xing","year":"2024","unstructured":"Xing P, Liu H, Xiao W, Zhang G, Zhang C, Liao Z, Li T, Yang J. The fusion gene LRP1-SNRNP25 drives invasion and migration by activating the pJNK\/37LRP\/MMP2 signaling pathway in osteosarcoma. Cell Death Discov. 2024;10(1):198. https:\/\/doi.org\/10.1038\/s41420-024-01962-z.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4355_CR31","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1038\/s41420-025-02536-3","volume":"11","author":"Z Wang","year":"2025","unstructured":"Wang Z, Sun H, Zhu S, Wang F, Li Q, Zhou J. RGS3 acts as a tumor promoter by facilitating the regulation of the TGF-\u03b2 signaling pathway and promoting EMT in ovarian cancer. Cell Death Discov. 2025;11(1):262. https:\/\/doi.org\/10.1038\/s41420-025-02536-3.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4355_CR32","doi-asserted-by":"publisher","first-page":"101771","DOI":"10.1016\/j.gendis.2025.101771","volume":"13","author":"C Liu","year":"2025","unstructured":"Liu C, Wang S, Zhang X, Han Y, Tan M, Fan J, Du J, Fan Y, Zhao X. The biomechanical signature of tumor invasion. Genes Dis. 2025;13(1):101771. https:\/\/doi.org\/10.1016\/j.gendis.2025.101771.","journal-title":"Genes Dis"},{"issue":"1","key":"4355_CR33","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1186\/s12967-025-06526-y","volume":"23","author":"Z Hao","year":"2025","unstructured":"Hao Z, Zhang M, Du Y, Liu J, Zeng G, Li H, Peng X. Invadopodia in cancer metastasis: dynamics, regulation, and targeted therapies. J Transl Med. 2025;23(1):548. https:\/\/doi.org\/10.1186\/s12967-025-06526-y.","journal-title":"J Transl Med"},{"issue":"1","key":"4355_CR34","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1186\/s12967-025-06328-2","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang H, Mao D, Che X, Chen Y, Liu Y. Understanding pre-metastatic niche formation: implications for colorectal cancer liver metastasis. J Transl Med. 2025;23(1):340. https:\/\/doi.org\/10.1186\/s12967-025-06328-2.","journal-title":"J Transl Med"},{"issue":"1","key":"4355_CR35","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/s41420-025-02837-7","volume":"11","author":"Q Wang","year":"2025","unstructured":"Wang Q, Tang A, Zhuang Q, Xu H, Xu S, Zhang J, Wang Y, Li L, Chu S, Wang Y, Bai J, Li M, Zhang R. TKT drives renal cell carcinoma progression through metabolic reprogramming and synergistic interaction with PKM2. Cell Death Discov. 2025;11(1):537. https:\/\/doi.org\/10.1038\/s41420-025-02837-7. PMID: 41253799; PMCID: PMC12627471.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4355_CR36","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","volume":"23","author":"A Zhang","year":"2024","unstructured":"Zhang A, Fan T, Liu Y, et al. Regulatory T cells in immune checkpoint blockade antitumor therapy. Mol Cancer. 2024;23(1):251. https:\/\/doi.org\/10.1186\/s12943-024-02156-y.","journal-title":"Mol Cancer"},{"key":"4355_CR37","doi-asserted-by":"publisher","first-page":"115009","DOI":"10.1016\/j.intimp.2025.115009","volume":"161","author":"J Xu","year":"2025","unstructured":"Xu J, Mo J, Jiang Y, et al. Tumor-associated macrophages in radiotherapy: mechanisms of polarization, immune regulation and therapeutic strategies. Int Immunopharmacol. 2025;161:115009. https:\/\/doi.org\/10.1016\/j.intimp.2025.115009.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"4355_CR38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s12935-024-03525-9","volume":"24","author":"MT Anvar","year":"2024","unstructured":"Anvar MT, Rashidan K, Arsam N, et al. Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies? Cancer Cell Int. 2024;24(1):355. https:\/\/doi.org\/10.1186\/s12935-024-03525-9.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4355_CR39","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12967-025-07518-8","volume":"24","author":"HK Rachamala","year":"2025","unstructured":"Rachamala HK, Nakka NMR, Dutta SK, Wang E, Mukhopadhyay D, Pal K. Strategic trimodal therapy enhances radiation-induced abscopal response in renal cancer. J Transl Med. 2025;24(1):31. https:\/\/doi.org\/10.1186\/s12967-025-07518-8.","journal-title":"J Transl Med"},{"issue":"1","key":"4355_CR40","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/s41420-025-02479-9","volume":"11","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Zhang S, Sun H, Xu L. The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma. Cell Death Discov. 2025;11(1):186. https:\/\/doi.org\/10.1038\/s41420-025-02479-9.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4355_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41420-025-02848-4","volume":"12","author":"W Yang","year":"2026","unstructured":"Yang W, Li Y, Li Z, Jiang C, Deng X, Peng D. HSP90AA1 restrains clear cell renal cell carcinoma progression by promoting CADM1 expression and suppressing the PI3K-AKT pathway through interaction with FBXO7. Cell Death Discov. 2026;12(1):6. https:\/\/doi.org\/10.1038\/s41420-025-02848-4.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4355_CR42","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1186\/s12967-025-07403-4","volume":"23","author":"C Dai","year":"2025","unstructured":"Dai C, Hu J, Tian X, Zhou H, Yang Z, Jin S, Zheng J. DCST1-AS1 promotes renal cell carcinoma progression via regulating the miR-582-5p\/HMGB2 axis. J Transl Med. 2025;23(1):1352. https:\/\/doi.org\/10.1186\/s12967-025-07403-4.","journal-title":"J Transl Med"},{"issue":"2","key":"4355_CR43","doi-asserted-by":"publisher","first-page":"101688","DOI":"10.1016\/j.gendis.2025.101688","volume":"13","author":"W Xie","year":"2025","unstructured":"Xie W, Fu Z, Skutella T, Jiang Q, Zhang R, Zhang Y. CTHRC1 promotes the progression of clear cell renal cell carcinoma via the PI3K\/AKT\/GSK3\u03b2 signaling pathway. Genes Dis. 2025;13(2):101688. https:\/\/doi.org\/10.1016\/j.gendis.2025.101688.","journal-title":"Genes Dis"},{"issue":"1","key":"4355_CR44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41420-025-02380-5","volume":"11","author":"W Yang","year":"2025","unstructured":"Yang W, Wu C, Jiang C, Jing T, Lu M, Xia D, Peng D. FDX1 overexpression inhibits the growth and metastasis of clear cell renal cell carcinoma by upregulating FMR1 expression. Cell Death Discov. 2025;11(1):115. https:\/\/doi.org\/10.1038\/s41420-025-02380-5.","journal-title":"Cell Death Discov"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04355-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04355-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04355-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T09:13:02Z","timestamp":1780391582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04355-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4355"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04355-x","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.cell.2018.02.052","asserted-by":"subject"}]},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"24 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have received approval from the review board of the First Affiliated Hospital of Xinxiang Medical College and follow the principles of the Declaration of Helsinki for all experimental studies in humans or animals. In addition, for studies involving human subjects, informed consent was obtained from the participants (No: EC-2024-682).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All patients provided written informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"239"}}